Ellington Healthcare Partners is a venture capital fund and invests in start-up and early-stage firms with unique therapeutic products and devices. The firm targeted investments are in the areas of Oncology, Nanotechnologies, Adult Stem Cells, and Bone Marrow-Derived Cells that demonstrate potential breakthroughs in the treatment of the disease or possess strong advantages over currently marketed products. Ellington Healthcare Asset Management is the manager of the fund.